“…Efforts to improve accuracy have led to the development of several nomograms. [41][42][43][44] Three important points should be noted: (1) these tools remained largely unvalidated in prospective studies; 41 (2) not all features can be determined for individuals undergoing penile conserving treatment; and (3) sensitivity, specificity, and false-negative rate are variable and are inferior to recent reports of high sensitivity (94%) using dynamic sentinel node biopsy. 45,46 Therefore when available, DSNB is preferred for risk stratification over nomograms.…”